- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
1.—(1) These Regulations may be cited as the Genetically Modified Food and Feed (Authorisations and Modifications of Authorisations) (Scotland) Regulations 2023 and come into force on 26 April 2023.
(2) These Regulations extend to Scotland.
2. In these Regulations—
“Regulation 1829/2003” means Regulation (EC) No. 1829/2003 of the European Parliament and of the Council on genetically modified food and feed,
“Regulation 1830/2003” means Regulation (EC) No. 1830/2003 of the European Parliament and of the Council concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC(1),
“Decision 2009/770” means Commission Decision 2009/770/EC establishing standards reporting formats for presenting the monitoring results of the deliberate release into the environment of genetically modified organisms, as or in products, for the purpose of the placing on the market, pursuant to Directive 2001/18/EC of the European Parliament and of the Council(2).
3.—(1) Schedules 1 to 7, which contain authorisations for products containing, consisting of, or produced from genetically modified organisms, have effect.
(2) Schedule 8, which contains an authorisation for products containing or consisting of genetically modified organisms, has effect.
(3) Subject to Articles 11(4) and 23(4) of Regulation 1829/2003, the authorisations set out in schedules 1 to 8 cease to have effect at the end of 25 April 2033.
4.—(1) Commission Decision 2011/891/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 (DAS-24236-5 × DAS-21Ø23-5) pursuant to Regulation (EC) No. 1829/2003 of the European Parliament and of the Council(3) is amended as follows.
(2) In Article 6 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 8 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
5.—(1) Commission Implementing Decision 2012/84/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean 356043 (DP-356Ø43-5) pursuant to Regulation (EC) No. 1829/2003 of the European Parliament and of the Council(4) is amended as follows.
(2) In Article 6 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 8 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
6.—(1) Commission Implementing Decision 2013/648/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON89034 × 1507 × NK603 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × MON-ØØ6Ø3-6) pursuant to Regulation (EC) No. 1829/2003 of the European Parliament and of the Council(5) is amended as follows.
(2) In Article 6 (authorisation holders), for paragraph 1, substitute—
“The authorisation holders are:
(a)Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, and
(b)Bayer CropScience LP, United States of America, represented in Great Britain by Bayer CropScience Limited.”.
(3) In Article 8 (addressees), for the text substitute—
“This Decision is addressed to:
(a)Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE, and,
(b)Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America, represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, England, CB4 0WB.”.
(4) In the Annex, for point (a) (applicants and authorisation holders) substitute—
“(a)Authorisation holders
(1) Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE, and
(2) Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America. represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, England, CB4 0WB.”.
7.—(1) Commission Implementing Decision 2013/650/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified (GM) maize MON 89034 × 1507 × MON88017 × 59122 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × MON-88Ø17-3 × DAS-59122-7), four related GM maizes combining three different single GM events (MON89034 × 1507 × MON88017 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × MON-88Ø17-3), MON89034 × 1507 × 59122 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × DAS-59122-7), MON89034 × MON88017 × 59122 (MON-89Ø34-3 × MON-88Ø17-3 × DAS-59122-7), 1507 × MON 88017 × 59122 (DAS-Ø15Ø7-1 × MON-88Ø17-3 × DAS-59122-7)) and four related GM maizes combining two different single GM events (MON89034 × 1507 (MON-89Ø34-3 × DAS-Ø15Ø7-1), MON89034 × 59122 (MON-89Ø34-3 × DAS-59122-7), 1507 × MON88017 (DAS-Ø15Ø7-1 × MON-88Ø17-3), MON 88017 × 59122 (MON-88Ø17-3 × DAS-59122-7)) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(6) is amended as follows.
(2) In Article 6 (authorisation holders), for paragraph 1, substitute—
“The authorisation holders are:
(a)Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, and
(b)Bayer CropScience LP, United States of America, represented in Great Britain by Bayer CropScience Limited.”.
(3) In Article 8 (addressees), for the text substitute—
“This Decision is addressed to:
(a)Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE, and
(b)Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America, represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, England, CB4 0WB.”.
(4) In the Annex, for point (a) (applicant and authorisation holders) substitute—
“(a)Authorisation holders
(1) Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE, and
(2) Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America. represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, England, CB4 0WB.”.
8.—(1) Commission Implementing Decision (EU) 2015/698 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean 305423 (DP-3Ø5423-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(7) is amended as follows.
(2) In Article 7 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
9.—(1) Commission Implementing Decision (EU) 2016/1215 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean FG72 (MST- FGØ72-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(8) is amended as follows.
(2) In Article 6 (authorisation holder) for the text substitute—
“The authorisation holder is Syngenta Crop Protection AG, Switzerland, represented in Great Britain by Syngenta Limited.”.
(3) In Article 8 (addressee) for the text substitute—
“This Decision is addressed to Syngenta Crop Protection AG, Rosentalstrasse 67, CH 4058 Basel, Switzerland, represented in Great Britain by Syngenta Limited of Jealott’s Hill International Research Centre, Bracknell, Berkshire, England, RG42 6EY.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Syngenta Crop Protection AG, Rosentalstrasse 67, CH 4058 Basel, Switzerland.
(2) The authorisation holder is represented in Great Britain by Syngenta Limited, Jealott’s Hill International Research Centre, Bracknell, Berkshire, England, RG42 6EY.”.
10.—(1) Commission Implementing Decision (EU) 2017/1211 authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(9) is amended as follows.
(2) In Article 6 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 8 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States if America, represented in Great Britain by Corteva Agriscience UK Limited Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
11.—(1) Commission Implementing Decision (EU) 2017/1212 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed(10) is amended as follows.
(2) In Article 6 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 8 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States if America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
12.—(1) Commission Implementing Decision (EU) 2017/2448 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean 305423 × 40-3-2 (DP-3Ø5423-1 × MON-Ø4Ø32-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed(11) is amended as follows.
(2) In Article 7 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States if America, represented in Great Britain by Corteva Agriscience UK Limited Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
13.—(1) Commission Implementing Decision (EU) 2017/2449 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean DAS-68416-4, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed(12) is amended as follows.
(2) In Article 7 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (authorisation holder) substitute—
“(a)Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
14.—(1) Commission Implementing Decision (EU) 2017/2450 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean DAS-44406-6, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed(13) is amended as follows.
(2) In Article 7 (authorisation holder)—
(a)in the heading, for “holder” substitute “holders”,
(b)for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, and M.S Technologies LLC, United States of America, both represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee)—
(a)in the heading, for “Addressee” substitute “addressees”,
(b)for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America and to M.S Technologies LLC, 103 Avenue D, West Point IA 52656, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (authorisation holder) substitute—
“(a)Authorisation holders
(1) The authorisation holders are—
Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, and
M.S Technologies LLC, 103 Avenue D, West Point, IA 52656, United States of America.
(2) Both authorisation holders are represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
15.—(1) Commission Implementing Decision (EU) 2017/2452 renewing the authorisation for the placing on the market of products containing, consisting of, or produced from genetically modified maize 1507 (DAS-Ø15Ø7-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(14) is amended as follows.
(2) In Article 7 (authorisation holders)—
(a)in the heading, for “holders” substitute “holder”, and
(b)for paragraphs 1 and 2 substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder:
(1) (1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) (2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
16.—(1) Commission Implementing Decision (EU) 2018/1109 renewing the authorisation for the placing on the market of products containing, consisting of, or produced from genetically modified maize 59122 (DAS-59122-7) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(15) is amended as follows.
(2) In Article 7 (authorisation holder)—
(a)in the heading, for “holders” substitute “holder”, and
(b)for paragraphs 1 and 2 substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee) for paragraphs 1 and 2 substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicants and authorisation holders) substitute—
“(a)Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
17.—(1) Commission Implementing Decision (EU) 2018/1110 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize 1507 × 59122 × MON 810 × NK603, and genetically modified maize combining two or three of the single events 1507, 59122, MON 810 and NK60, and repealing Decisions 2009/815/EC, 2010/428/EU and 2010/432/EU(16) is amended as follows.
(2) In Article 7 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 10 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
18.—(1) Commission Implementing Decision (EU) 2019/1304 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize 4114 (DP-ØØ4114-3), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(17) is amended as follows.
(2) In Article 7 (authorisation holder) for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee) for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
19.—(1) Commission Implementing Decision (EU) 2019/1306 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize 1507 × NK603 (DAS-Ø15Ø7-1 × MON-ØØ6Ø3-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Amendment of Commission Implementing Decision (EU) 2019/1304(18) is amended as follows.
(2) In Article 7 (authorisation holders)—
(a)in the heading, for “holders” substitute “holder”,
(b)for paragraphs 1 and 2 substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressees)—
(a)in the heading, for “Addressees” substitute “addressee”,
(b)for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicants and authorisation holders) substitute—
“(a)Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
20.—(1) Commission Implementing Decision (EU) 2019/2085 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × NK603 × DAS-40278-9 and sub-combinations MON 89034 × NK603 × DAS-40278-9, 1507 × NK603 × DAS-40278-9 and NK603 × DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(19) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited Cpc2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, CPC2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
21.—(1) Commission Implementing Decision (EU) 2019/2086 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS-40278-9 and genetically modified maize combining two, three or four of the single events MON 89034, 1507, MON 88017, 59122 and DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(20) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”.
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, CPC2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a)Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana, 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, CPC2 Capital Park, Fulbourn, Cambridge, England, CB21 5XE.”.
22. The Genetically Modified Food and Feed (Authorisations) (Scotland) Regulations 2022 are amended as follows—
(a)in regulation 4(e) for “89304” substitute “89034”.
(b)in schedule 2, in paragraph 4(2) for “EURL-VL-0417VP”, substitute “EURL-VL-04/17VP”.
(c)in schedule 3, in paragraph 4(2) for “EURL-VL-0417VP” substitute “EURL-VL-03/12VP”.
(d)in schedule 4, in paragraph 4(2) for “EURL-VL-0417VP” substitute “EURL-VL-03/12VP”.
(e)in schedule 7, in paragraph 4(2) for “EURL-VL-0417VP” substitute “EURL-VL-03/12VP”.
23. Commission Decision 2010/429/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 88017 × MON 810 (MON-88Ø17-3 × MON-ØØ81Ø-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(21) is revoked.
MAREE TODD
Authorised to sign by the Scottish Ministers
St Andrew’s House,
Edinburgh
28th February 2023
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Policy Note sets out a brief statement of the purpose of a Scottish Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Scottish Statutory Instrument accessible to readers who are not legally qualified and accompany any Scottish Statutory Instrument or Draft Scottish Statutory Instrument laid before the Scottish Parliament from July 2012 onwards. Prior to this date these type of notes existed as ‘Executive Notes’ and accompanied Scottish Statutory Instruments from July 2005 until July 2012.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: